| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.003 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.34 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |